Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This stock plunges more often than a Pelican behind a school of fish. I guess investors are tired of waiting for the oft-promised but not-yet-delivered CGM device.
I fully expect CYCA to start bringing in revenue leading to a recovery of the share price. However, if it doesn't, the cash value of CYCA based on the RMIC shares it owns will still drive up the price. There is roughly a 100:1 ratio between the ~500M OS of CYCA and the 5M shares of RMIC. If RMIC shares reach $20 then CYCA shares should, in theory, be worth at least $.20. The shares are almost a guaranteed steal at these prices. I'll be buying whenever I can.
Given that there are 426M shares outstanding (300M of them are restricted) a potential distribution could be 1 share of RMIC for every 100 shares of CYCA.
I agree with an earlier poster that CYCA shareholders will fare better if CYCA continues to hold them and structures some type of dividend in the future. With RMIC shares going public in the $5-$7 range, this could add 20+ cents to the value of CYCA shares.
You may have a long wait since we may be near a low price. Because the pre-split low price was a little above $.40, I expected the SP to drop to a little above 15x$.40=$6. The factory should be open soon (more than a month ago they said a few weeks, but ABML time is always optimistic) and the price will probably pop once the factory is open and revenues start coming in.
Dropping like a rock... this crew just can't seem to get things moving. The factory was supposed to open by 3Q2022 but it looks like they were off by at least a year.
It's been crickets here for a while... will they ever start/finish their PIII trial?
Still no news about the factory that was scheduled to start operations a year ago? What do these guys do all day - sit around drinking coffee and writing obscure grant applications? This delay reflects an unacceptable level of incompetence and poor planning.
Still crickets on the opening of the plant... the latest target I had seen posted was the fall of 2022 (which was already 1-2 years past the earlier targets). Seems that BB companies no longer believe in meeting targets these days - "Targets! Targets! Targets are for Shmucks"
I think they set the floor with the recent private placement at $.70 so it won't go down to $.55. The plant should open soon (it's way past due) at which point this will begin moving up quickly.
I'd be buying more of this if/when it drops below $.75
I had sold a bunch of this around $.75 last fall because it kept dropping and I bought it back when it fell below $.45 in Feb. They announced the results of the Tonopah assay a week or two later and the price jumped to $1.40. I don't think we'll see prices below $.70 again for ABML.
Based on the 15% rise in ABML today it looks like the Fernley plant might be opening soon :)
When is the Fernley plant supposed to open? This was originally projected to open 2 years ago, then promised last year, and the latest information seemed to suggest April of this year with the hiring of the plant manager in January and the $20M loan to purchase the black mass produced in phase 1. The plant has been under construction for well over a year now, why can't they seem to get their act in gear?
I got the information from an individual in the know... the KNW team previously indicated that they expected the prototype soon, but I don't think they would/could disclose this milestone until they had the device in hand. Even when they get the first manufactured device I'm sure they will be making modifications before producing the final device that goes to the FDA.
The last that I heard is that they are still on track to uplist to the NYSE in the next 1-2 months. They might be in a quiet period in advance of the uplist.
I heard a live talk (no recording) given by one of the execs who indicated they have $800M worth of potential work in their sales pipeline. Of course this is not signed contracts but is still quite promising. Also, they are located in FL right near major defense tech contractors and aerospace/drone companies (e.g., L3/Harris, General Dynamics, etc.) so there is alot of synergy in their neighborhood.
Agreed that they will probably have to do a reverse split but I don't think it will be 10:1. Usually companies with outlandish dilution will do a 10:1 or even 100:1... they could probably get by with a 4:1 or 5:1 reverse split to get them over the $2 mark.
The term "Artificial Intelligence" is used very loosely. Straightforward predictive models, which have been imbedded everywhere for decades, are frequently labelled Artificial Intelligence. At the other extreme are the more recent natural language AI platforms such as Chat GPT which have generated alot of controversy and might face potential regulation.
I think that the "Artificial Intelligence" built into the KNW GCM device is primarily a predictive model, possibly a more complicated neural network, but still a relatively straightforward predictive model which would not be regulated beyond performance verification to support FDA approval.
As noted by others, if you're shorting based on the presence of AI in the KNW device you will be sorely disappointed.
Technology Company News published a brief interview with Josh Cryer from RM... the link is
HERE
Is it a coincidence that KNW SP is cratering shortly after the departure of Phil Bosua as CEO? Is his departure causing the plunge in price or did he jump ship in anticipation of upcoming problems?
It's hard not to worry in the face of a 40% drop in KNW stock over the past 3 months with little hopeful news coming out of the company. Little did I expect, when I invested in this company 5 years ago, that it would take them so long to get anything out the door. The Particle bulb is the only thing they've been able to finish in that time and it appears to be a complete disaster.
Did Mike provide any new info on Thursday's program?
In the last interview he gave he mentioned the dosing study that is underway and mentioned that it would be followed by the Phase III trial "if funding is available". I sure hope the Phase III trial is performed.
In the interview, Mike Sheck indicated that they are starting their "dose optimization" study. After the study is completed they will then begin their phase III trials... of course he qualified this by adding "if funding is available".
When will this stock ever take off?